4.5 Review

Emerging molecular targets in melanoma invasion and metastasis

期刊

PIGMENT CELL & MELANOMA RESEARCH
卷 26, 期 1, 页码 39-57

出版社

WILEY
DOI: 10.1111/pcmr.12041

关键词

molecular targets; melanoma; invasion; metastasis; anticancer therapy; plasticity

资金

  1. Cancer Research UK [C33043/A12065]
  2. Royal Society [RG110591]
  3. Cancer Research UK [12065] Funding Source: researchfish

向作者/读者索取更多资源

Metastatic cutaneous melanoma accounts for the majority of skin cancer deaths due to its aggressiveness and high resistance to current therapies. To efficiently metastasize, invasive melanoma cells need to change their cytoskeletal organization and alter contacts with the extracellular matrix and the surrounding stromal cells. Melanoma cells can use different migratory strategies depending on varying environments to exit the primary tumour mass and invade surrounding and later distant tissues. In this review, we have focused on tumour cell plasticity or the interconvertibility that melanoma cells have as one of the factors that contribute to melanoma metastasis. This has been an area of very intense research in the last 5 yr yielding a vast number of findings. We have therefore reviewed all the possible clinical opportunities that this new knowledge offers to both stratify and treat cutaneous malignant melanoma patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma

Oscar Maiques, Bruce Fanshawe, Eva Crosas-Molist, Irene Rodriguez-Hernandez, Alessia Volpe, Gaia Cantelli, Lena Boehme, Jose L. Orgaz, Faraz K. Mardakheh, Victoria Sanz-Moreno, Gilbert O. Fruhwirth

Summary: This study utilized bioinformatic analyses, in vitro validation, and tissue histology to investigate the mechanisms and effects of metastasis-inhibiting drugs in melanoma. The Rho kinase-myosin II pathway was identified as a potential therapeutic target, leading to the proposal of a migrastatic drug development pipeline.

BRITISH JOURNAL OF CANCER (2021)

Article Dermatology

Location, location, location: Melanoma cells living at the edge

Oscar Maiques, Victoria Sanz-Moreno

Summary: Abnormal cell migration and invasion are major challenges in cancer treatment, especially in the case of melanoma which is known for its high migratory and metastatic potential. Melanoma cells utilize various migratory strategies controlled by cytoskeletal remodelling, with particular emphasis on the importance of amoeboid invasive melanoma strategies. These strategies are facilitated by signaling pathways such as Rho-ROCK-Myosin II and are actionable in clinical settings.

EXPERIMENTAL DERMATOLOGY (2022)

Review Physiology

RHO GTPase SIGNALING IN CANCER PROGRESSION AND DISSEMINATION

Eva Crosas-Molist, Remi Samain, Leonie Kohlhammer, Jose L. Orgaz, Samantha L. George, Oscar Maiques, Jaume Barcelo, Victoria Sanz-Moreno

Summary: This review examines the role of Rho GTPase signaling in different stages of cancer progression, highlighting its importance in tumor initiation, proliferation, and metastasis, as well as its involvement in cell migration, interaction with the tumor microenvironment, and inflammation regulation.

PHYSIOLOGICAL REVIEWS (2022)

Article Oncology

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma

Juliana B. Candido, Oscar Maiques, Melanie Boxberg, Verena Kast, Eleonora Peerani, Elena Tomas-Bort, Wilko Weichert, Amiram Sananes, Niv Papo, Viktor Magdolen, Victoria Sanz-Moreno, Daniela Loessner

Summary: Kallikrein-related peptidases are upregulated in pancreatic cancer and associated with poor prognosis. Inhibiting KLK may be a potential therapeutic strategy for precision medicine.

CANCERS (2021)

Review Cell Biology

Cytoskeletal Remodelling as an Achilles' Heel for Therapy Resistance in Melanoma

Adrian Barreno, Jose L. Orgaz

Summary: Discusses the poor prognosis of melanoma and the issue of treatment resistance, highlighting the dependence of resistant cells on cytoskeletal signaling pathways, which can be targeted for future interventions.
Article Oncology

Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxan-Delgado, Oscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J. G. Drake, Jesus Gomez-Escudero, Frances M. Richards, Celine Weller, Christof Dormann, Ya-Ming Meng, Peter B. Vermeulen, Dieter Saur, Victoria Sanz-Moreno, Ping-Pui Wong, Cyrill Geraud, Pedro R. Cutillas, Kairbaan Hodivala-Dilke

Summary: This study reveals that endothelial cell focal adhesion kinase (FAK) plays a role in regulating pancreatic ductal adenocarcinoma (PDAC) metastasis and impacting the outcome of gemcitabine treatment. The findings suggest the potential clinical utility of combinatorial endothelial cell FAK targeting with gemcitabine in controlling metastasis in PDAC patients.

CANCER RESEARCH (2022)

Review Cell Biology

The amoeboid state as part of the epithelial-to-mesenchymal transition programme

Vittoria Graziani, Irene Rodriguez-Hernandez, Oscar Maiques, Victoria Sanz-Moreno

Summary: This review focuses on the role of amoeboid behavior in cancer cell invasion and metastasis, as well as the molecular biomarkers and physicochemical triggers associated with it. The authors suggest that targeting these characteristics could lead to therapeutic opportunities for cancer treatment.

TRENDS IN CELL BIOLOGY (2022)

Article Oncology

Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth

Anna Perdrix Rosell, Oscar Maiques, Joshua Alexander James Martin, Probir Chakravarty, Luigi Ombrato, Victoria Sanz-Moreno, Ilaria Malanchi

Summary: The functional connection between cancer cells and their surrounding TME plays a crucial role in cancer development. Experimental evidence shows that perturbing the secretory profile of aggressive breast cancer cells can alter the tumor microenvironment, leading to the infiltration of anti-tumor macrophages and affecting long-term tumor growth.

CANCER LETTERS (2022)

Review Oncology

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies

Rebecca Adams, Gabriel Osborn, Bipashna Mukhia, Roman Laddach, Zena Willsmore, Alicia Chenoweth, Jenny L. C. Geh, Alastair D. MacKenzie Ross, Ciaran Healy, Linda Barber, Sophia Tsoka, Victoria Sanz-Moreno, Katie E. Lacy, Sophia N. Karagiannis

Summary: The application of monoclonal antibodies in the treatment of melanoma has significantly improved clinical management over the last decade, but more than half of patients do not benefit from treatment. Targeting tumor-associated macrophages (TAMs) and exploring new treatment strategies based on their diversity and plasticity hold promise for enhancing treatment success.

ONCOIMMUNOLOGY (2022)

Article Cell Biology

LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion

Yaiza Jung-Garcia, Oscar Maiques, Joanne Monger, Irene Rodriguez-Hernandez, Bruce Fanshawe, Marie-Charlotte Domart, Matthew J. Renshaw, Rosa M. Marti, Xavier Matias-Guiu, Lucy M. Collinson, Victoria Sanz-Moreno, Jeremy G. Carlton

Summary: Metastasis involves cancer cells spreading from the primary tumor to other sites. Researchers discovered increased expression of the protein LAP1 in metastatic melanoma cells, primary melanoma tumors, and metastases. They found that a shorter isoform of LAP1, LAP1C, supports constrained cell migration and invasion by allowing a weaker coupling between the nuclear envelope and the nuclear lamina. This suggests that LAP1 contributes to melanoma aggressiveness.

NATURE CELL BIOLOGY (2023)

Editorial Material Genetics & Heredity

NECTIN1 is a melanoma metastasis suppressor gene

Jaume Barcelo, Victoria Sanz-Moreno

Summary: A new study reveals how the loss of NECTIN1 leads to melanoma dissemination after local depletion of IGF1.

NATURE GENETICS (2022)

Review Cell Biology

Amoeboid migration in health and disease: Immune responses versus cancer dissemination

Samantha George, Joshua Alexander James Martin, Vittoria Graziani, Victoria Sanz-Moreno

Summary: Cell migration plays a crucial role in immune responses and cancer metastasis. Amoeboid migrating cells use myosin II-powered blebs to move and change their shape and direction. Both immune cells and metastatic cancer cells utilize amoeboid migration, but with different purposes and processes. Exploring the similarities and differences between amoeboid immune and cancer cells can enhance our understanding of metastasis and provide insights for targeted therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Review Oncology

Preclinical to clinical utility of ROCK inhibitors in cancer

Jaume Barcelo, Remi Samain, Victoria Sanz-Moreno

Summary: ROCK belongs to the AGC family of Ser/Thr protein kinases and is involved in various cellular processes. It plays a crucial role in regulating cytoskeletal dynamics through actomyosin contractility, which is important for cell migration, proliferation, and survival in many cancer types. Targeting ROCK and its downstream effectors holds potential for cancer treatment, and local use of ROCK inhibitors may reduce side effects. Therefore, different therapeutic strategies and the latest generation of ROCK inhibitors are proposed for clinical use.

TRENDS IN CANCER (2023)

Article Biochemical Research Methods

Protocol to drive human monocyte-to-macrophage polarization in vitro using tumor conditioned media

Samantha George, Mirella Georgouli, Victoria Sanz-Moreno

Summary: This article presents a protocol to drive human monocyte-macrophage differentiation using tumor-derived conditioned media and characterize TAMs in vitro, including isolation of CD14+ cells, induction of macrophage polarization, morphological assessment of macrophages, and validation of their functional behaviors with a tumor cell killing assay.

STAR PROTOCOLS (2022)

Article Biochemical Research Methods

Multiplex chromogenic immunohistochemistry to stain and analyze paraffin tissue sections from the mouse or human

Oscar Maiques, Victoria Sanz-Moreno

Summary: This article describes a multiplex chromogenic immunohistochemistry platform for staining and analyzing two markers in paraffin tissue sections from mouse or human. The protocol involves stripping and re-probing steps followed by image analysis, allowing reliable and affordable multiplex imaging.

STAR PROTOCOLS (2022)

暂无数据